Skip to main content

Table 2 Surgical morbidity after LND. Lymphatic fistulas are defined as persistent secretion of lymphatic fluid for 21 days or more after LND. Wound infection was assumed if any typical symptoms (e. g., redness, purulent discharge, abscess formation) were detected. Neurological complications were defined if symptoms like postoperative paraesthesia or loss of motor function was detected. Severe bleeding was defined as bleeding that needs to be surgically revised

From: Morbidity and oncologic outcome after saphenous vein-sparing inguinal lymphadenectomy in melanoma patients

   Overall SaphRes SaphSpar p value
Lympatic fistula [%] 50.5 51.6 48.8 0.7809
Wound infection [%] 28.6 31.3 24.4 0.4478
Severe bleeding [%] 5.7 7.7 2.4 0.2543
Neurological complications [%] 1.9 1.5 2.4 0.7400
Need for surgical revision [%] 18.9 20.0 17.1 0.7076
Lymphedema 6 months after LNDa [%] 28.6 30.0 26.5 0.7252
Lymphedema 12 months after LNDb [%] 20.9 22.9 18.8 0.6796
  1. aOnly patients with a complete 6-month follow-up after LND were considered. Data available in 84 cases (50 SaphRes, 34 SaphSpar)
  2. bOnly patients with a complete 12-month follow-up after LND were considered. Data available in 67 cases (35 SaphRes, 32 SaphSpar)